Development Level

Tbio 4 | 10,625
Tchem 3 | 1,890

IMPC Term

preweaning lethality, complete... 4 | 633
abnormal behavioral response t... 1 | 52
abnormal bone structure 1 | 131
increased exploration in new e... 1 | 56

Disease

ovarian cancer 6 | 8,484
invasive ductal carcinoma 4 | 2,950
malignant mesothelioma 4 | 3,162
osteosarcoma 4 | 7,933
Cancer 3 | 2,346
ductal carcinoma in situ 3 | 1,745
glioblastoma 3 | 5,572
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung cancer 3 | 4,466
nasopharyngeal carcinoma 3 | 1,056
adrenocortical carcinoma 2 | 1,427
astrocytic glioma 2 | 2,241
colon cancer 2 | 1,475
group 3 medulloblastoma 2 | 2,254
interstitial cystitis 2 | 2,299
medulloblastoma, large-cell 2 | 6,234
non-small cell lung cancer 2 | 2,798
oligodendroglioma 2 | 2,849
pediatric high grade glioma 2 | 2,712
primitive neuroectodermal tumor 2 | 3,031
psoriasis 2 | 6,685
sonic hedgehog group medulloblastoma 2 | 1,482
Animal Mammary Neoplasms 1 | 136
Atopic dermatitis 1 | 944
Barth syndrome 1 | 23
Bloom syndrome 1 | 30
Breast cancer 1 | 3,094
Endometriosis 1 | 535
Glaucoma 1 | 134
Liver Cirrhosis 1 | 101
MHC class II deficiency 1 | 2
Mammary Neoplasms, Experimental 1 | 150
Mantle cell lymphoma 1 | 18
Multiple myeloma 1 | 1,327
Neoplasms, Second Primary 1 | 6
Peripheral Neuropathy 1 | 303
Pick disease 1 | 1,893
Rheumatoid Arthritis 1 | 1,160
Sleeping sickness 1 | 37
astrocytoma 1 | 1,493
atypical teratoid / rhabdoid tumor 1 | 4,369
breast carcinoma 1 | 1,614
esophageal adenocarcinoma 1 | 737
fibroadenoma 1 | 557
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
lung carcinoma 1 | 2,844
non primary Sjogren syndrome sicca 1 | 840
pancreatic cancer 1 | 2,300
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
posterior fossa group A ependymoma 1 | 1,511
primary Sjogren syndrome 1 | 789
primary pancreatic ductal adenocarcinoma 1 | 1,271
progressive supranuclear palsy 1 | 674
spina bifida 1 | 1,064
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis and treatment for 6 months 1 | 686

Tissue

Blood and immune system 7 | 17,995
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Liver and Pancreas 7 | 18,136
Male tissues 7 | 17,969
Nervous System 7 | 18,561
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444

Target Family

Non-IDG 5 | 11,971
Enzyme 1 | 4,146
Kinase 1 | 634

Grant Application

5R01GM064778-02 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cell cycle checkpoint control protein RAD9A RAD9A Tbio Non-IDG -2.13903 136.3 864
Cell cycle checkpoint protein RAD17 RAD17 Tbio Non-IDG -2.05235 111.4 432
Cell division cycle 7-related protein kinase CDC7 Tchem Kinase -2.21236 175.1 209
Phosphatidate cytidylyltransferase 1 CDS1 Tbio Enzyme -1.16732 14.9 45
Protein DBF4 homolog A DBF4 Tchem Non-IDG -1.88132 73.4 145
Checkpoint protein HUS1 HUS1 Tbio Non-IDG -1.86001 66.4 154
Cell cycle checkpoint protein RAD1 RAD1 Tchem Non-IDG -1.99891 98.1 211